Completed NCT01214135
This study is completed in Sweden. It is testing Use of Seroquel Extended Release (XR) and Immediate Release (IR) for schizophrenia.
Multiple locations, including Falköping Why is this study shown? This study is directly about Schizophrenia.
Schizophrenia Observational i A study where researchers collect information without assigning a treatment. From 18 Years to 65 Years
Countries Sweden
Sponsor AstraZeneca
Condition Schizophrenia Completed NCT01947803
This summary needs review. Please check the official study record and contact the research team for details.
Multiple locations, including Baoding Why is this study shown? This study is directly about Schizophrenia.
Schizophrenia Drug i A study involving a medication or substance. From 18 Years to 65 Years
Countries China
Sponsor Xian-Janssen Pharmaceutical Ltd.
Condition Schizophrenia Completed NCT01150448
This summary needs review. Please check the official study record and contact the research team for details.
Multiple locations, including Cerritos Why is this study shown? This study is directly about Schizophrenia.
Schizophrenia Drug From 18 Years to 65 Years
Countries United States, Belgium, Croatia, ...
Sponsor Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Condition Schizophrenia Completed NCT00119756
This study is completed. It is testing paliperidone Palmitate Injected for schizophrenia.
Location not clearly listed Why is this study shown? This study is directly about Schizophrenia.
Schizophrenia Drug Over 18 Years
Countries
Sponsor Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Condition Schizophrenia Completed NCT00845026
This summary needs review. Please check the official study record and contact the research team for details.
Multiple locations, including Escondido Why is this study shown? This study is directly about Schizophrenia.
Schizophrenia Drug From 18 Years to 65 Years
Countries United States, Germany, Mexico, ...
Sponsor Denovo Biopharma LLC
Condition Schizophrenia Completed NCT03565068
This study is completed in the United States. It is testing MK-8189 for schizophrenia.
In Glendale Why is this study shown? This study is directly about Schizophrenia.
Schizophrenia Behavioral From 18 Years to 60 Years
Countries United States
Sponsor Merck Sharp & Dohme LLC
Condition Schizophrenia Completed NCT02205099
This study is completed in the United States. It is testing Multiple Oral Doses of SKL15508 for schizophrenia.
In Glendale Why is this study shown? This study is directly about Schizophrenia.
Schizophrenia Drug From 18 Years to 60 Years
Countries United States
Sponsor SK Life Science, Inc.
Condition Schizophrenia Completed NCT00525304
This summary needs review. Please check the official study record and contact the research team for details.
In Baltimore Why is this study shown? This study is directly about Schizophrenia.
Schizophrenia Behavioral From 18 Years to 64 Years
Countries United States
Sponsor University of Maryland, Baltimore
Condition Schizophrenia Completed NCT01942161
This summary needs review. Please check the official study record and contact the research team for details.
Multiple locations, including Chubu Region Why is this study shown? This study is directly about Schizophrenia.
Schizophrenia Drug From 13 Years to 17 Years
Countries Japan
Sponsor Otsuka Pharmaceutical Co., Ltd.
Condition Schizophrenia Completed NCT00640510
This summary needs review. Please check the official study record and contact the research team for details.
Multiple locations, including Fukushima Why is this study shown? This study is directly about Schizophrenia.
Schizophrenia Drug From 20 Years to 64 Years
Countries Japan
Sponsor Eli Lilly and Company
Condition Schizophrenia Completed NCT00649844
This study is completed in Italy. It focuses on schizophrenia.
Multiple locations, including Città di Castello Why is this study shown? This study is directly about Schizophrenia.
Schizophrenia Drug Over 18 Years
Countries Italy
Sponsor Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Condition Schizophrenia Terminated NCT00645515
This summary needs review. Please check the official study record and contact the research team for details.
Multiple locations, including Bilbao Why is this study shown? This study is directly about Schizophrenia.
Schizophrenia Drug From 18 Years to 70 Years
Countries Spain
Sponsor Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Condition Schizophrenia